GME — Geratherm Medical AG Income Statement
0.000.00%
Last trade - 00:00
- €23.12m
- €20.78m
- €25.85m
- 82
- 68
- 28
- 64
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.3 | 19.9 | 27.5 | 23.9 | 25.9 |
Cost of Revenue | |||||
Gross Profit | 14.1 | 13.7 | 17.6 | 16.3 | 16.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 19.5 | 18.8 | 24.4 | 23.4 | 23.9 |
Operating Profit | 1.86 | 1.05 | 3.04 | 0.49 | 1.91 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.35 | 1.04 | 2.72 | 0.308 | 1.73 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.558 | 0.29 | 1.9 | 0.333 | 1.08 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.929 | 0.546 | 2.05 | 0.122 | 1.02 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.929 | 0.546 | 2.05 | 0.122 | 1.02 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.188 | 0.11 | 0.413 | 0.128 | 0.274 |
Dividends per Share |